Indian J Sex Transm Dis Indian J Sex Transm Dis
Official Publication of the Indian Association for the Study of Sexually Transmitted Diseases
Indian J Sex Transm Dis
The Journal | Search | Ahead Of Print | Current Issue | Archives | Instructions | Subscribe | Login    Users online: 813   Home Email this page Print this page Bookmark this page Decrease font size Default font size Increase font size


 
  Table of Contents  
CASE REPORT
Year : 2015  |  Volume : 36  |  Issue : 2  |  Page : 204-206
 

Vulvar invasive squamous cell carcinoma in a young patient with Human Immunodeficiency Virus-seropositivity


Department of DVL, Andhra Medical College, Visakhapatnam, Andhra Pradesh, India

Date of Web Publication12-Oct-2015

Correspondence Address:
Sravani Sandhya Bellam
117/12 Part, B2 Taj Villas, Opposite to Dolphin Apartments, Behind Taj Gateway Hotel, Maharanipeta, Visakhapatnam - 530 002, Andhra Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0253-7184.167180

Rights and Permissions

 

   Abstract 

Vulvar squamous cell carcinomas (SCC) are rare malignancy of unknown etiology. Only 10% of these tumors occur under the age of 40 years. We are describing one such rare case where a 29-year-old female patient had presented with nonhealing ulcer over vulva since 4 months. Histopathology revealed invasive SCC of the vulva. The occurrence of invasive vulvar SCC in a younger patient is rare. In this patient, it is most likely precipitated by immunodeficiency caused by Human Immunodeficiency Virus.


Keywords: Immunosuppression, malignancy in young, vulvar intraepithelial neoplasia, vulvar squamous cell carcinoma


How to cite this article:
Rao T, Bellam SS, Gurupuprasad P. Vulvar invasive squamous cell carcinoma in a young patient with Human Immunodeficiency Virus-seropositivity. Indian J Sex Transm Dis 2015;36:204-6

How to cite this URL:
Rao T, Bellam SS, Gurupuprasad P. Vulvar invasive squamous cell carcinoma in a young patient with Human Immunodeficiency Virus-seropositivity. Indian J Sex Transm Dis [serial online] 2015 [cited 2019 Nov 18];36:204-6. Available from: http://www.ijstd.org/text.asp?2015/36/2/204/167180



   Introduction Top


Vulvar and vaginal squamous cell carcinomas (VV-SCC) are rare malignancies with a world-standardized annual incidence of around 1-3 per 100,000 women. [1] The disease occurs mainly among women in their 60s or 70s. The etiology of VV-SCC remains incompletely understood. Although many hypotheses have been proposed in the etiology of vulvar cancer, it has no specific factor. Historically the only common variable is a chronic itch-scratch cycle. Prior studies have reported infection with human papillomavirus (HPV) types are associated with high-risk HPVs (hrHPVs) of cervical cancer to be etiologically involved in VV-SCC. [2] Other risk factors, including lifetime number of male sexual partners, genital warts, tobacco smoking, and low socioeconomic status are involved. However, other, yet poorly defined etiologic factors that influence the risk of VV-SCC either without or in conjunction with hrHPV infection must exist.

The relationship between HPV infection and female lower genital tract neoplasia has been established in the past 20 years. During the same period of time, studies have also shown that patients infected with Human Immunodeficiency Virus (HIV) have a propensity to develop certain neoplastic diseases. [3] Conley et al. showed a 16-fold increase in the development of vulvovaginal and perianal condylomata acuminata or intraepithelial neoplasia in a cohort of HIV-infected women compared with uninfected women. [4] Another series found that HIV-infected patients had a 3.3-fold increased risk of recurrent or persistent vulvar intraepithelial neoplasia after treatment compared with HIV-uninfected patients. [5]


   Case report Top


A 29-year-old female patient presented to the dermatology department with a nonhealing ulcer on the vulva of 4 months duration. It was associated with severe itching and burning sensation. She also complained of loss of weight over 10 kg over 3 months. Her medical history revealed that she was a housewife married for 6 years with no extramarital exposure. The patient's known HIV-risk factor was her husband, who was reportedly HIV-positive. Physical examination revealed a moderately built women with an erythematous verrucous indurated growth measuring about 2 cm Χ 1 cm over the right side of labia majora, covered with dirty grayish-white precipitate [Figure 1]. There was no enlargement of lymph nodes and on careful examination rest of vagina and cervix were normal. Onychomycosis of fingernails and toenails were seen. CD4 count is 216 cells/mm 3 pap smear was normal and colposcopic examination of cervix and vagina were normal. Histopathology of the lesion from labia majora revealed focally invasive moderately differentiated SCC [Figure 2] and [Figure 3]. Her chest X-ray was found to be normal and computed tomography-abdomen revealed ill-defined soft tissue lesion in the vaginal region. Laboratory studies confirmed HIV. The patient was put on tenofovir, lamivudine, and efavirenz. The patient was in stage1 vulvar cancer, and she underwent modified radical vulvectomy with primary closure [Figure 4]. Postoperative recovery was uneventful, and no recurrence was seen over a follow-up period of 9 months.
Figure 1: Closer view of the verrucous growth

Click here to view
Figure 2: Low power ‑.pointer shows malignant changes

Click here to view
Figure 3: High power ‑ infiltration in squamous epithelium showing atypical cell with nuclear hyperchromasia, pleomorphism

Click here to view
Figure 4: After surgery modified radical vulvectomy with primary closure

Click here to view



   Discussion Top


According to National AIDS control organization HIV estimations 2012-2013, the estimated number of people living with HIV/AIDS in India were 20.89 lakhs (15-49 age group). Over the past 15 years, it has become widely accepted that there is an association between cervical disease and infection with the HIV. [6],[7] Invasive cervical cancer was designated in 1993 as an AIDS case defining illness by the Centers for Disease Control and Prevention. [3] Since both cervical and vulvar cancers share certain risk factors, and invasive cervical cancer can occur simultaneously or metachronously with invasive vulvar cancer. A 23-fold risk increase for vulvar/vaginal cancer has been shown for people who have received organ transplants. Similarly, HIV-positive women appear to be an increased risk of vaginal cancer and precancer, though the magnitude of the increased risk varies in published papers from around 7 (vulvar and vaginal cancer combined) to 21 times higher. [8]

There are only nine reported cases of invasive vulvar cancer in HIV-seropositive women in the literature. Eight of the nine reported patients were younger than 40 years of age. The youngest patient reported was a 12-year-old with vertically acquired HIV infection. [9]

Carcinoma of the vulva is uncommon, and it is a disease of elderly women. Our study has demonstrated that invasive vulvar carcinoma is not uncommon in younger age group and this could be linked to immunosuppression. Vulvar cancer can occur independent of hormonal influence as there is no difference in binding capacity of estrogen receptors in normal, atrophic and malignant skin. Without properly functioning immune system tumor cells escape destruction and proliferate unchecked. The genetic factor control various factors such as individual susceptibility and ability to activate and deactivate carcinogens, to produce interferons, which may affect patient susceptibility to viral infections and malignancies and regulation of the immune system. Therefore, our patient developed invasive squamous cell cancer due to immunosuppression caused by HIV infection. [10] Management of invasive vulvar cancer in this young population needs to be balanced between appropriate curative surgery, which will often be radical, versus the desire to perform less mutilating surgery in young women. Treatment often depends on the stage of the disease. So we have opted for modified radical vulvectomy with primary closure.

With increasingly comprehensive care and more effective antiretroviral and antimicrobial therapies, HIV-infected patients with compromised immunity are now surviving for extended periods of time. We can expect that lower genital tract neoplasia is likely to become a more common presentation of HIV disease among infected women, and hence strategies need to be developed for early detection and treatment of anogenital neoplasia and invasive malignancies in the setting of HIV-induced immunodeficiency.


   Conclusion Top


Due to the rarity of primary vulvar carcinoma, the clinical behavior of this neoplasm in the HIV-infected patient is poorly understood. Our case indicates that although vulvar carcinoma is a disease of the elderly, young women infected with HIV are predisposed to vulvar carcinoma. This should be considered as a serious condition in HIV-infected patients. Clinicians caring for HIV-infected women should be careful to routinely examine the vulva and perianal region and to biopsy any suspicious areas for early diagnosis and treatment to improve patients prognosis.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
   References Top

1.
Ansink AC, Heintz AP. Epidemiology and etiology of squamous cell carcinoma of the vulva. Eur J Obstet Gynecol Reprod Biol 1993;48:111-5.  Back to cited text no. 1
    
2.
Mabuchi K, Bross DS, Kessler II. Epidemiology of cancer of the vulva. A case-control study. Cancer 1985;55:1843-8.  Back to cited text no. 2
    
3.
Lee YC, Holcomb K, Buhl A, Holden J, Abulafia O. Rapid progression of primary vaginal squamous cell carcinoma in a young HIV-infected woman. Gynecol Oncol 2000;78 (3 Pt 1):380-2.  Back to cited text no. 3
    
4.
Conley LJ, Ellerbrock TV, Bush TJ, Chiasson MA, Sawo D, Wright TC. HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neo-plasia: A prospective cohort study. Lancet 2002;359:108-13.  Back to cited text no. 4
    
5.
Bersoff-Matcha SJ, Horgan MM, Fraser VJ, Mundy LM, Stoner BP. Sexually transmitted disease acquisition among women infected with Human Immunodeficiency Virus type 1. J Infect Dis 1998;178:1174-7.  Back to cited text no. 5
    
6.
Wright TC. Invasive cervical cancer and cervical intraepithelial neo-plasia in women infected with the Human Immunodeficiency Virus. Clin Consult Obstet Gynecol 1994;6 : 11-21.  Back to cited text no. 6
    
7.
Wright TC. Cervical disease in HIV-infected women: Prevalence, pathogenesis, detection, and treatment. In: Luesley D, Jordan J, Richart M, editors. Intraepithelial Neoplasia of the Lower Genital Tract. Edinburg: Churchill Livingstone; 1995. p. 263-77.  Back to cited text no. 7
    
8.
Kumar P, Kumar R, Jha AK, Mallik SK, Raihan M, Anand V, et al. Rapidly growing noduloulcerative lesion in the perineum in a Human Immunodeficiency Virus infected patient. Indian J Sex Transm Dis 2014;35:68-70.  Back to cited text no. 8
[PUBMED]  Medknow Journal  
9.
Giaquinto C, Del Mistro A, De Rossi A, Bertorelle R, Giacomet V, Ruga E, et al. Vulvar carcinoma in a 12-year-old girl with vertically acquired Human Immunodeficiency Virus infection. Pediatrics 2000;106:E57.  Back to cited text no. 9
    
10.
Carter J, Carlson J, Fowler J, Hartenbach E, Adcock L, Carson L, et al. Invasive vulvar tumors in young women - A disease of the immunosuppressed? Gynecol Oncol 1993;51:307-10.  Back to cited text no. 10
    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4]



 

Top
Print this article  Email this article
 

    

 
  Search
 
  
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Article in PDF (1,639 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
   Introduction
   Case report
   Discussion
   Conclusion
    References
    Article Figures

 Article Access Statistics
    Viewed1182    
    Printed18    
    Emailed0    
    PDF Downloaded39    
    Comments [Add]    

Recommend this journal